UFP Technologies Director Cynthia Feldmann Sells 1,000 Shares

Cynthia L. Feldmann, a director at UFP Technologies, sold 1,000 shares of the company's common stock on August 13, 2026, as disclosed in a SEC Form 4 filing. The transaction value, determined by the weighted average sale price of $324.26, amounted to approximately $324,260. Following the sale, the estimated post-transaction value of the shares, based on the market close on August 13, 2026, was around $319,860.

UFP Technologies is a mid-sized medical device component manufacturer with a market capitalization of $2.3 billion and trailing twelve-month (TTM) revenues of $631.6 million. The company reported a net income of $72.3 million for the TTM period, showcasing robust profitability. UFP Technologies' stock has experienced a significant one-year appreciation of 43.5%, indicating investor confidence in the company's specialized manufacturing capabilities and its exposure to burgeoning medical device markets.

The company's competitive edge is rooted in its proprietary expertise in advanced foam, film, and plastic engineering, coupled with its well-established relationships with prominent medical device manufacturers and healthcare providers.